RedLeaf Biologics

Lexington, KY · Founded 2015 · Privately Held (backing)

Producer of natural pigment products intended to offer an alternative to chemical dyes and antioxidant additives consumed in today's world. RedLeaf Biologics is based in Lexington, KY and was founded in 2015. It was valued at $14.8 million at its seed round in Nov 2019, the last priced event on record. It has raised $1.3 million across 2 recorded rounds; the latest was a $750,000 seed round in Sep 2019.

PMV mark · valuation
$14.8M
Oct 2026
Priced at
its seed round
Nov 2019
Total raised
$1.3M
Last round
Seed Round
Sep 2019
What is RedLeaf Biologics worth?
$14.8MPrivateMarketView mark · Oct 2026

Valued at $14.8M at its seed round, Nov 2019. Nothing has traded since.

Free account
More of RedLeaf Biologics with a free account
  • ·Watch RedLeaf Biologics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

RedLeaf Biologics funding history

2 rounds
DateRoundRaisedPost-money
Sep 2019Seed Round$750K▮
Jun 2015Seed Round$250K▮
Unlock post-money valuations

Membership and data by Private Market View

RedLeaf Biologics valuation

RedLeaf Biologics was valued at $14.8 million at its seed round in Nov 2019. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has RedLeaf Biologics raised?

RedLeaf Biologics has raised $1.3 million in total; 2 of its rounds are on record. The largest on record was a $750,000 seed round in Sep 2019.

RedLeaf Biologics has filed 4 Form Ds with the SEC since 2016, most recently in Nov 2019 ($750,000 sold to 2 investors).

How RedLeaf Biologics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For RedLeaf Biologics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about RedLeaf Biologics

What is RedLeaf Biologics worth?
RedLeaf Biologics is valued at $14.8M as of Oct 2026. Valued at $14.8M at its seed round, Nov 2019. Nothing has traded since.
How much has RedLeaf Biologics raised?
RedLeaf Biologics has raised $1.3M in total funding across 2 recorded rounds.
When did RedLeaf Biologics last raise?
RedLeaf Biologics last raised in Sep 2019 (Seed Round), raising $750K.